PT3419970T - Novos derivados de pirrolidina - Google Patents

Novos derivados de pirrolidina

Info

Publication number
PT3419970T
PT3419970T PT177056629T PT17705662T PT3419970T PT 3419970 T PT3419970 T PT 3419970T PT 177056629 T PT177056629 T PT 177056629T PT 17705662 T PT17705662 T PT 17705662T PT 3419970 T PT3419970 T PT 3419970T
Authority
PT
Portugal
Prior art keywords
pyrrolidine derivatives
novel pyrrolidine
novel
derivatives
pyrrolidine
Prior art date
Application number
PT177056629T
Other languages
English (en)
Original Assignee
H Hoffnabb La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Hoffnabb La Roche Ag filed Critical H Hoffnabb La Roche Ag
Publication of PT3419970T publication Critical patent/PT3419970T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT177056629T 2016-02-26 2017-02-22 Novos derivados de pirrolidina PT3419970T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16157679 2016-02-26

Publications (1)

Publication Number Publication Date
PT3419970T true PT3419970T (pt) 2020-02-28

Family

ID=55443159

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177056629T PT3419970T (pt) 2016-02-26 2017-02-22 Novos derivados de pirrolidina

Country Status (31)

Country Link
US (1) US10689339B2 (pt)
EP (1) EP3419970B1 (pt)
JP (1) JP6952044B2 (pt)
KR (1) KR102797060B1 (pt)
CN (1) CN108699044B (pt)
AR (1) AR107717A1 (pt)
AU (1) AU2017224343B2 (pt)
CA (1) CA3011652C (pt)
CL (1) CL2018002347A1 (pt)
CO (1) CO2018007756A2 (pt)
CR (1) CR20180404A (pt)
DK (1) DK3419970T3 (pt)
ES (1) ES2775781T3 (pt)
HR (1) HRP20200307T1 (pt)
HU (1) HUE047842T2 (pt)
IL (1) IL260130B (pt)
LT (1) LT3419970T (pt)
MA (1) MA43667B1 (pt)
MX (1) MX381332B (pt)
MY (1) MY196560A (pt)
PH (1) PH12018501585B1 (pt)
PL (1) PL3419970T3 (pt)
PT (1) PT3419970T (pt)
RS (1) RS59938B1 (pt)
RU (1) RU2736498C1 (pt)
SG (1) SG11201807074VA (pt)
SI (1) SI3419970T1 (pt)
TW (1) TWI740903B (pt)
UA (1) UA122084C2 (pt)
WO (1) WO2017144483A1 (pt)
ZA (1) ZA201804120B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3575284T3 (pl) 2017-01-24 2021-12-27 Astellas Pharma Inc. Związek prolinamidu podstawiony fenylodifluorometylem
TWI846731B (zh) 2018-09-18 2024-07-01 瑞士商赫孚孟拉羅股份公司 組織蛋白酶(cathepsin)S抑制劑之對抗抗藥抗體形成之用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595073A (en) * 2009-04-20 2012-11-30 Hoffmann La Roche Proline derivatives as cathepsin inhibitors
CN103930400B (zh) * 2011-11-11 2016-04-20 霍夫曼-拉罗奇有限公司 制备1-酰基-4-苯基磺酰基脯氨酰胺衍生物的方法及中间体
RU2014123784A (ru) * 2011-11-25 2015-12-27 Ф. Хоффманн-Ля Рош Аг Новые производные пирролидина в качестве ингибиторов катепсина
CN104114068B (zh) * 2011-12-09 2017-07-11 W.C.布拉德利公司 具有可调整的加热特征的烹饪炉排
EP2814822B1 (en) * 2012-02-17 2016-04-20 F.Hoffmann-La Roche Ag Novel pyrrolidine derivatives
PE20150995A1 (es) * 2012-08-21 2015-06-29 Hoffmann La Roche Nuevos derivados de piridina

Also Published As

Publication number Publication date
PH12018501585B1 (en) 2021-03-31
WO2017144483A1 (en) 2017-08-31
CA3011652C (en) 2024-01-09
MX2018009638A (es) 2018-09-11
CN108699044B (zh) 2022-03-04
AU2017224343A1 (en) 2018-07-05
HRP20200307T1 (hr) 2020-06-12
SG11201807074VA (en) 2018-09-27
CA3011652A1 (en) 2017-08-31
TW201733981A (zh) 2017-10-01
LT3419970T (lt) 2020-03-10
JP2019506416A (ja) 2019-03-07
HUE047842T2 (hu) 2020-05-28
ES2775781T3 (es) 2020-07-28
JP6952044B2 (ja) 2021-10-20
EP3419970A1 (en) 2019-01-02
KR102797060B1 (ko) 2025-04-18
CL2018002347A1 (es) 2018-11-30
EP3419970B1 (en) 2020-01-01
AU2017224343B2 (en) 2020-09-10
IL260130A (en) 2018-07-31
KR20180111862A (ko) 2018-10-11
RS59938B1 (sr) 2020-03-31
TWI740903B (zh) 2021-10-01
RU2736498C1 (ru) 2020-11-17
CO2018007756A2 (es) 2018-10-10
US20180362461A1 (en) 2018-12-20
MA43667B1 (fr) 2020-03-31
IL260130B (en) 2020-08-31
MX381332B (es) 2025-03-12
PH12018501585A1 (en) 2019-04-08
PL3419970T3 (pl) 2020-06-01
CR20180404A (es) 2018-10-18
MY196560A (en) 2023-04-19
UA122084C2 (uk) 2020-09-10
US10689339B2 (en) 2020-06-23
ZA201804120B (en) 2020-07-29
CN108699044A (zh) 2018-10-23
SI3419970T1 (sl) 2020-04-30
AR107717A1 (es) 2018-05-23
DK3419970T3 (da) 2020-03-02

Similar Documents

Publication Publication Date Title
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
ZA201800826B (en) Substituted oxopyridine derivatives
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
IL271607A (en) New azaquinoline histories
GB201603779D0 (en) Novel compounds
IL253381A0 (en) History of h9-pyrrolo-dipyridine
IL258656A (en) Indoline-2-ion derivatives
EP3193604A4 (en) Substituted pyrrolidine compounds
ZA201802235B (en) Pyrrolidine derivatives
EP3193609A4 (en) Substituted pyrrolidine carboxamide compounds
IL251005B (en) Pyrido-oxazinone derivatives
SMT201900438T1 (it) Nuovi derivati di cyp-eicosanoide
IL254711A0 (en) History of Indole
ZA201804120B (en) Novel pyrrolidine derivatives
PL3469691T3 (pl) Konfiguracja szyku halbacha
PT3319956T (pt) Derivados de oxopiridina substituída
GB201617952D0 (en) For you
GB201614243D0 (en) Tjti&tjtd
GB201614244D0 (en) Tjti&tjtd
GB201614173D0 (en) Tjti&tjtd
EP3287440A4 (en) Pyrrolidine compound